期刊文献+

多囊卵巢综合征患者体外受精-胚胎移植不同降调节方案的比较 被引量:3

Comparison of different down-regulation protocols of in vitro fertilization-embryo transfer for treatment of patients with polycystic ovarian syndrome
下载PDF
导出
摘要 目的探讨长方案与短方案对于多囊卵巢综合征患者(PCOS)的治疗结局。方法收集2008年至2010年在我中心行体外受精-胚胎移植/卵胞浆内单精子注射(IVF/ICSI)治疗的PCOS患者共135例临床资料,按不同的降调节方案,分为长方案A组和短方案B组,回顾性分析两组的治疗结局。比较两组间患者年龄、不育年限、体重指数、基础卵泡刺激素(FSH)、基础黄体生成素(LH),促性腺激素(Gn)用药总量、人绒毛膜促性腺激素(hCG)日雌二醇(E_2)值、获卵数、受精率、优质胚胎率、种植率、临床妊娠率、流产率、活产率和卵巢过度刺激综合征(OHSS)发生率。结果 A组的Gn用量、获卵数、OHSS的发生率显著高于B组,差异有统计学意义(P<0.05);两组间hCG日E_2值、受精率、优质胚胎率、种植率、临床妊娠率、流产率,活产率,无统计学意义(P>0.05)。结论短方案较长方案Gn用量少,缩短治疗的时间,且OHSS发生率低,减轻了患者经济和精神负担,更适合PCOS患者。 Objective: To investigate the outcomes between long and short protocols for treatment of patients with polycystic ovarian syndrome(PCOS). Methods. A total of 135 infertile women with PCOS undergoing IVF/ICSI in our center were enrolled in this retrospective study. According to the different down-regulation protocols, the patients were divided into two groups, the long protocol group (group A) and the short protocol group (group B). The patients' age, infertile years, body mass index, baseline FSH ~ LH, baseline T, gonadotropin (Gn) used, serum estradiol concentration on the day of hCG injection, retrieved oocytes, fertilization rate, high quality embryo rate, clinical pregnancy rate, abortion rate, live birth rate, incidence of ovarian hyperstimulation syndrome (OHSS) were compared between the two groups. Results: The Gn used, retrieved oocytes, incidence of OHSS in group A were significantly higher than those in group B (P 〈 0. 05). There were no statistically significant differences in serum estradiol concentration on the day of hCG injection, retrieved oocytes, fertilization rate, high quality embryo rate, clinical pregnancy rate, abortion rate and live birth rate between the two groups (P〉0.05). Conclusions. Compared to the long protocol, the short protocol had advantages of shorter time, fewer Gn used, and lower OHSS incidence. The economic and psychological burdens of patients were milder. So it was more acceptable for PCOS.
出处 《生殖医学杂志》 CAS 2012年第5期436-439,共4页 Journal of Reproductive Medicine
关键词 多囊卵巢综合征 长方案 短方案 卵巢过度刺激综合征 体外受精-胚胎移植 Polycystic ovarian syndrome (PCOS) Long protocol Short protocol Ovarian hyperstimulation syndrome (OHSS) In vitro fertilization-embryo transfer
  • 相关文献

参考文献17

  • 1姚晶萍,王秀霞,吴效科,倪延群,高磊.多囊卵巢综合征的研究进展[J].首都医药,2006,13(6):32-34. 被引量:4
  • 2Homburg R. The management of infertility associated with polycystic ovary syndrome [J]. Reprod Biol Endocrinol, 2003, 1.-109.
  • 3The rotterdam ESHRE /ASRM sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long term health risks related to polycystic ovary syndrome(PCOS) [J]- HumReprod, 2004, 19(1): 41 47.
  • 4范光升.卵巢过度刺激综合征(OHSS)[J].中国计划生育学杂志,2007,15(8):505-506. 被引量:26
  • 5于丛一,周灿权,庄广伦.卵巢过度刺激综合征发生危险因素的logistic回归分析[J].中华妇产科杂志,2002,37(8):491-492. 被引量:18
  • 6Swanton A, Storey L, McVeigh E, et al. IVF outcome in women with PCOS, PCO and normal ovarian morphologyrJ]. Eur J Obstet Gynecol Reprod Biol, 2010,149 (1) : 68-71.
  • 7吴成平,谷玉,李静,赵芳.体外受精-胚胎移植治疗PCOS不孕分析[J].中国优生与遗传杂志,2009,17(1):91-92. 被引量:9
  • 8Bstandig B, C6drin2DurneHn I, Hugues JN, et aL Effectiveness of low dose of gonadotropin releasing hormone agonist on hormonal flare-up[J]. Assis Reprod Genet, 2000, 17(2) : 113-116.
  • 9李红.一过性升高(flare-up)在促排卵中的应用[J].生殖医学杂志,2007,16(5):317-318. 被引量:2
  • 10Hazout A, de Ziegler D, Cornel C, et al. Comparison of short 7 day and prolonged treatment with gonadotropin- releasing hormone agonist desensitization for controlled ovarian hyperstimulation [J]. Fertil Steril, 1993, 59 (3): 596-600.

二级参考文献42

  • 1何柏松,P.C.HO,田秦杰.多囊卵巢综合征[J].生殖医学杂志,2004,13(6):334-337. 被引量:20
  • 2胡咏华,徐键,吴丽萍.不同剂量长效抑那通在体外受精-胚胎移植中的治疗效果观察[J].浙江医学,2006,28(11):892-895. 被引量:5
  • 3Duna IF A. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis [ J ]. Endocr Rev, 1997, 18 (6) : 774 -800.
  • 4Regan L, Owene J, Jacobs HS. Hypersecretion of luteinizing hormone, infertility, and miscarriage[J]. Lancet, 1990, 336 (8724): 1141- 1144.
  • 5Hwang JL,Seow KM,Lin YH,et al. Ovarian stimulation by concomitant administration of cetrorelix acetate and HMG following Diane - 35 pretreatment for patients with polycystic ovary syndrome:a prospective randomized study [ J ]. Hum Reprod ,2004 Sep, 19 ( 9 ) : 1993 - 2000.
  • 6Urman B, Fluker MR, Yuen BH, et al. The outcome of in vitro fertilization and embryo transfer in women with polycystic ovary syndrome failing to conveive after ovulation induction with exogenous gonacbtropins[ J ]. Fertile Steril , 1992,57 (6) : 1269 - 1273.
  • 7Richard B RP, et al. Polycystic ovary syndrome : patho - physiology and outcome with in vitro fertilization [ J ]. Fertile Steril, 1996,65 ( 1 ) :1 - 10.
  • 8Olivennnes F, et al. The single or dual administration of the gonadotropin - releasing hormone antagonist Cetrorelix in an in vitro fertilization - embryo transfer program [ J ]. Fertil Steril, 1994,62 ( 3 ) :468.
  • 9Tesarik J, Mendoza C. Effects of exogenous LH administration during ovarian stimulation of pituitary down - regulated young oocyte donors on oocyte yield and developmental competence [ J ]. Hum Reprod, 2002,17(12) :3129 -3137.
  • 10Tesarik J. Luteinizing hormone affects uterine receptivity independently of ovarian function[J]. RBM Online,2003,7( 1 ) :59 -64.

共引文献61

同被引文献46

  • 1曹泽毅.中华妇产科学[M].第2版.北京:人民卫生出版社,2005,1457.
  • 2Hart R,Hickey M,Franks S.Definitions,prevalence and symptoms of polycystic ovaries and polycystic ovary syndrome[J].Best Pract Res Clin Obstet Gynaecol,2004,18:671-683.
  • 3Teede H,Deeks A,Moran L.Polycystic ovary syndrome:a complex condition with psychological,reproductive and metabolic manifestations that impacts on health across the lifespan[J].BMC Med,2010,8:41-51.
  • 4Agarwal A,Aponte-Mellado A,Premkumar BJ,et al.The effects of oxidative stress on female reproduction:a review[J].Reprod Biol Endocrinol,2012,10:49-80.
  • 5Seleem AK,El Refaeey AA,Shaalan D,et al.Superoxide dismutase in polycystic ovary syndrome patients undergoing intracytoplasmic sperm injection[J].J Assist Reprod Genet,2014,31:499-504.
  • 6Escobar-Morreale HF,Luque-Ramírez M,González F.Circulating inflammatory markers in polycystic ovary syndrome:a systematic review and meta analysis[J].Int J Fertil Steril,2011,95:1048-1058.
  • 7Fauser BC,Tarlatzis BC,Rebar RW,et al.Consensus on women’s health aspects of polycystic ovary syndrome(PCOS):the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group[J].Int J Fertil Steril,2012,97:28-38.
  • 8Murri M,Luque-Ramírez M,Insenser M,et al.Circulating markers of oxidative stress and polycystic ovary syndrome(PCOS):a systematic review and meta-analysis[J].Hum Reprod Update,2013:1-21.
  • 9Carbone MC,Tatone C,Delle Monache S,et al.Antioxidant enzymatic defences in human follicular fluid:characterization and age‐dependent changes[J].Mol Hum Reprod,2003,9:639-643.
  • 10Gao H,Meng J,Xing H,et al.Association of heme oxygenase-1with the risk of polycystic ovary syndrome in non-obese women[J].Hum Reprod,2014,29:1058-1066.

引证文献3

二级引证文献51

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部